DK2094676T3 - Ny fremgangsmåde til fremstillingen af 2-iminothiazolidin-4-on-derivater - Google Patents

Ny fremgangsmåde til fremstillingen af 2-iminothiazolidin-4-on-derivater

Info

Publication number
DK2094676T3
DK2094676T3 DK07849225.3T DK07849225T DK2094676T3 DK 2094676 T3 DK2094676 T3 DK 2094676T3 DK 07849225 T DK07849225 T DK 07849225T DK 2094676 T3 DK2094676 T3 DK 2094676T3
Authority
DK
Denmark
Prior art keywords
iminothiazolidin
derivatives
preparation
new procedure
procedure
Prior art date
Application number
DK07849225.3T
Other languages
Danish (da)
English (en)
Inventor
Stefan Abele
Martin Bolli
Gunther Schmidt
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Application granted granted Critical
Publication of DK2094676T3 publication Critical patent/DK2094676T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/54—Nitrogen and either oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK07849225.3T 2006-11-23 2007-11-22 Ny fremgangsmåde til fremstillingen af 2-iminothiazolidin-4-on-derivater DK2094676T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2006054409 2006-11-23
PCT/IB2007/054752 WO2008062376A2 (en) 2006-11-23 2007-11-22 New process for the preparation of 2-imino-thiazolidin-4-one derivatives

Publications (1)

Publication Number Publication Date
DK2094676T3 true DK2094676T3 (da) 2013-06-10

Family

ID=39316391

Family Applications (2)

Application Number Title Priority Date Filing Date
DK07849225.3T DK2094676T3 (da) 2006-11-23 2007-11-22 Ny fremgangsmåde til fremstillingen af 2-iminothiazolidin-4-on-derivater
DK12000613.5T DK2489662T3 (da) 2006-11-23 2007-11-22 Mellemprodukter af en ny fremgangsmåde til fremstillingen af 5-benzyliden-2-alkylimino-3-phenylthiazolidin-4-on derivater

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK12000613.5T DK2489662T3 (da) 2006-11-23 2007-11-22 Mellemprodukter af en ny fremgangsmåde til fremstillingen af 5-benzyliden-2-alkylimino-3-phenylthiazolidin-4-on derivater

Country Status (13)

Country Link
US (1) US8263780B2 (enExample)
EP (2) EP2094676B1 (enExample)
JP (1) JP4669564B2 (enExample)
KR (1) KR101255879B1 (enExample)
CN (2) CN101541772B (enExample)
AU (1) AU2007323042B2 (enExample)
CA (1) CA2669069C (enExample)
DK (2) DK2094676T3 (enExample)
ES (2) ES2410793T3 (enExample)
IL (1) IL198847A (enExample)
MX (1) MX2009005048A (enExample)
TW (1) TWI460166B (enExample)
WO (1) WO2008062376A2 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE43833E1 (en) 2003-11-21 2012-11-27 Actelion Pharmaceuticals Ltd. Thiazolidin-4-one derivatives
EP1689726B1 (en) 2003-11-21 2010-10-06 Actelion Pharmaceuticals Ltd. 5-(benz- (z) -ylidene) -thiazolidin-4-one derivatives as immunosuppressant agents
US8912340B2 (en) 2006-11-23 2014-12-16 Actelion Pharmaceuticals Ltd. Process for the preparation of 2-imino-thiazolidin-4-one derivatives
KR20100134032A (ko) 2008-03-17 2010-12-22 액테리온 파마슈티칼 리미티드 선별적 ｓ1ｐ₁ 수용체 작동약에 대한 투약 섭생
GB0819182D0 (en) 2008-10-20 2008-11-26 Actelion Pharmaceuticals Ltd Crystalline forms
PT2885266T (pt) * 2012-08-17 2020-05-29 Actelion Pharmaceuticals Ltd Processo para a preparação de (2z,5z)-5-(3-cloro-4-((r)-2,3-di-hidropropoxi)benzilideno)-2-(propilimino)-3-(o-tolil)tiazolidin-4-ona e intermediário utilizado no referido processo
MA41139A (fr) 2014-12-11 2017-10-17 Actelion Pharmaceuticals Ltd Combinaison pharmaceutique comportant un agoniste sélectif du récepteur sip1
KR20200013086A (ko) 2014-12-11 2020-02-05 액테리온 파마슈티칼 리미티드 선택적 s1p1 수용체 효능제에 대한 투약 섭생
JOP20190207A1 (ar) 2017-03-14 2019-09-10 Actelion Pharmaceuticals Ltd تركيبة صيدلانية تشتمل على بونيسيمود
WO2019060147A1 (en) * 2017-09-19 2019-03-28 Teva Pharmaceuticals Usa, Inc. NEW CRYSTALLINE POLYMORPHE FROM PONESIMOD
US11013723B1 (en) 2018-10-16 2021-05-25 Celgene Corporation Solid forms of a thiazolidinone compound, compositions and methods of use thereof
US11014897B1 (en) 2018-10-16 2021-05-25 Celgene Corporation Solid forms comprising a thiazolidinone compound, compositions and methods of use thereof
US11014940B1 (en) 2018-10-16 2021-05-25 Celgene Corporation Thiazolidinone and oxazolidinone compounds and formulations
US11186556B1 (en) 2018-10-16 2021-11-30 Celgene Corporation Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof
CN114040910A (zh) * 2019-07-10 2022-02-11 拜耳公司 制备2-(苯基亚氨基)-1,3-噻唑烷-4-酮的方法
US20220251053A1 (en) * 2019-07-10 2022-08-11 Bayer Aktiengesellschaft Process of preparing 2-(phenylimino)-1,3-thiazolidin-4-ones
KR20220093330A (ko) 2019-10-31 2022-07-05 이도르시아 파마슈티컬스 리미티드 Cxcr7 안타고니스트와 s1p1 수용체 조절인자의 조합
KR20200019639A (ko) 2020-01-30 2020-02-24 전대연 만남의 스마트 도착시스템
MX2022010058A (es) * 2020-02-18 2022-08-25 Bayer Ag Procedimiento para la preparacion de 2-(fenilimino)-3-alquil-1,3-t iazolidin-4-onas.
US20240368094A1 (en) 2021-08-17 2024-11-07 Teva Czech Industries S.R.O Polymorphs of ponesimod
EP4212156A1 (en) 2022-01-13 2023-07-19 Abivax Combination of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine and its derivatives with a s1p receptor modulator
WO2023152691A1 (en) * 2022-02-10 2023-08-17 Metrochem Api Pvt Ltd Process for the preparation of ponesimod and its intermediates thereof
CN117924210A (zh) * 2024-01-22 2024-04-26 赣南师范大学 一种2-亚氨基噻唑烷-4-酮类化合物的制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3077402A (en) * 1954-12-06 1963-02-12 Polaroid Corp Photographic color processes, products, and compositions
NL270002A (enExample) 1960-10-08
OA03835A (fr) 1970-07-17 1971-12-24 Rhone Poulenc Sa Nouveaux dérivés de la thiazolidine, leur préparation et les compositions qui les contiennent.
WO1991017151A1 (en) * 1990-04-27 1991-11-14 Orion-Yhtymä Oy New pharmacologically active catechol derivatives
TW221689B (enExample) * 1991-08-27 1994-03-11 Otsuka Pharma Co Ltd
ATE212018T1 (de) * 1993-02-26 2002-02-15 Otsuka Pharma Co Ltd Thiazole oder imidazole derivate als maillard reaktion inhibitoren
KR960022486A (ko) 1994-12-29 1996-07-18 김준웅 신규 티아졸리딘-4-온 유도체
US6353006B1 (en) * 1999-01-14 2002-03-05 Bayer Corporation Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
US6818640B1 (en) 1999-09-14 2004-11-16 Shionogi & Co., Ltd. 2-imino-1,3-thiazine derivatives
US6380229B1 (en) * 1999-11-12 2002-04-30 Fujimoto Co., Ltd. 2-(N-cyanoimino)thiazolidin-4-one derivatives
US20050019825A9 (en) * 2002-03-15 2005-01-27 Qing Dong Common ligand mimics: pseudothiohydantoins
AU2003255528B2 (en) 2002-07-10 2009-07-16 Merck Serono Sa Azolidinone-vinyl fused-benzene derivatives
GB0217152D0 (en) 2002-07-24 2002-09-04 Novartis Ag Organic compounds
PL377564A1 (pl) * 2002-11-22 2006-02-06 Smithkline Beecham Corporation Nowe związki chemiczne
US20040167192A1 (en) * 2003-01-16 2004-08-26 David Solow-Cordero Methods of treating conditions associated with an Edg-7 receptor
EP1689726B1 (en) * 2003-11-21 2010-10-06 Actelion Pharmaceuticals Ltd. 5-(benz- (z) -ylidene) -thiazolidin-4-one derivatives as immunosuppressant agents
WO2005082901A1 (en) * 2004-02-25 2005-09-09 Smithkline Beecham Corporation Novel chemical compounds
WO2006094233A1 (en) * 2005-03-03 2006-09-08 Sirtris Pharmaceuticals, Inc. N,n'-dicyclic isothiourea sirtuin modulators
KR20100134032A (ko) * 2008-03-17 2010-12-22 액테리온 파마슈티칼 리미티드 선별적 ｓ1ｐ₁ 수용체 작동약에 대한 투약 섭생
GB0819182D0 (en) * 2008-10-20 2008-11-26 Actelion Pharmaceuticals Ltd Crystalline forms

Also Published As

Publication number Publication date
KR101255879B1 (ko) 2013-04-17
ES2523401T3 (es) 2014-11-25
WO2008062376A3 (en) 2008-07-10
BRPI0718986A2 (pt) 2014-02-11
WO2008062376A2 (en) 2008-05-29
JP2010510976A (ja) 2010-04-08
TW200831474A (en) 2008-08-01
IL198847A (en) 2015-07-30
ES2410793T3 (es) 2013-07-03
IL198847A0 (en) 2010-02-17
US8263780B2 (en) 2012-09-11
EP2489662A1 (en) 2012-08-22
TWI460166B (zh) 2014-11-11
DK2489662T3 (da) 2014-10-20
CA2669069A1 (en) 2008-05-29
CN103087004A (zh) 2013-05-08
EP2489662B1 (en) 2014-08-06
CA2669069C (en) 2015-02-17
EP2094676A2 (en) 2009-09-02
MX2009005048A (es) 2009-05-25
CN101541772B (zh) 2013-04-17
CN101541772A (zh) 2009-09-23
AU2007323042A1 (en) 2008-05-29
EP2094676B1 (en) 2013-04-10
AU2007323042B2 (en) 2012-12-20
KR20090081009A (ko) 2009-07-27
US20110201821A2 (en) 2011-08-18
JP4669564B2 (ja) 2011-04-13
US20100317867A1 (en) 2010-12-16

Similar Documents

Publication Publication Date Title
DK2094676T3 (da) Ny fremgangsmåde til fremstillingen af 2-iminothiazolidin-4-on-derivater
DK2086944T3 (da) Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater
DK2431359T3 (da) Fremgangsmåde til fremstilling af diaminophenothiaziniumforbindelser
DK2046264T3 (da) Fremgangsmåder til fremstillingen af sammensætninger med film
DK2231565T3 (da) Fremgangsmåder til fremstilling af clorerede carbonhydrider
DK1893586T3 (da) Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler
DK1981859T3 (da) Fremstilling af delmopinol
DK1828164T3 (da) Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK1778668T3 (da) Fremgangsmåde til fremstilling af dihydropteridion
DK1981863T3 (da) Fremgangsmåde til fremstilling af aminocrotonylaminosubtituerede quinazolinderivater
DK2155838T3 (da) Fremgangsmåde til fremstilling af forgrenede carbonhydrider
DK2048941T3 (da) Fremgangsmåde til opdræt af rovmider
DK2010498T3 (da) Syntese af acylaminoalkenylenamider, der kan anvendes som substans P-antagonister
DOP2007000084A (es) Derivados de dihidropirazolopirimidinona
DK2114886T3 (da) Fremgangsmåde til fremstilling af visse substituerede sulfiliminer
CR10562A (es) Nuevos derivados de piridazina
DK1981875T3 (da) Substituerede indolylalkylaminoderivater som inhibitorer af histondeacetylase
DK1852430T3 (da) Fremgangsmåde til fremstilling af proanthocyanidinoligomer
DK1884507T3 (da) Fremgangsmåde til fremstilling af glycerol
CR10809A (es) Derivados de heteroaril-pirrolidinil-y-piperidinil-cetona
DK2201020T3 (da) Fremgangsmåde til fremstilling af 2' -deoxy-5-azacytidin (decitabin)
DK2146944T3 (da) Fremgangsmåde til fremstillingen af 18f-mærkede folater
NO20055643D0 (no) Preparation of lodixanol
DK2044099T3 (da) Fremgangsmåde til fremstillingen af s-fluormethyl-6,9-difluor-11-hydroxy-16-methyl-17-propionyloxy-3-oxo-androsta-1,4-dien-17-carbothiat og mellemprodukter
DK2285416T3 (da) Konjugat til behandlingen af mesotheliom